Works matching DE "RALTEGRAVIR"

Results: 569
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo.

    Published in:
    Cancers, 2021, v. 13, n. 4, p. 861, doi. 10.3390/cancers13040861
    By:
    • Alburquerque-González, Begoña;
    • Bernabé-García, Ángel;
    • Bernabé-García, Manuel;
    • Ruiz-Sanz, Javier;
    • López-Calderón, Fernando Feliciano;
    • Gonnelli, Leonardo;
    • Banci, Lucia;
    • Peña-García, Jorge;
    • Luque, Irene;
    • Nicolás, Francisco José;
    • Cayuela-Fuentes, María Luisa;
    • Luchinat, Enrico;
    • Pérez-Sánchez, Horacio;
    • Montoro-García, Silvia;
    • Conesa-Zamora, Pablo;
    • Roche, Serge
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

    Published in:
    International Journal of STD & AIDS, 2012, v. 23, n. 7, p. 459, doi. 10.1258/ijsa.2012.011391
    By:
    • Bucciardini, R.;
    • D'Ettorre, G.;
    • Baroncelli, S.;
    • Ceccarelli, G.;
    • Parruti, G.;
    • Weimer, L. E.;
    • Fragola, V.;
    • Galluzzo, C. M.;
    • Pirillo, M. F.;
    • Lucattini, S.;
    • Bellagamba, R.;
    • Francisci, D.;
    • Ladisa, N.;
    • Antoni, A. Degli;
    • Guaraldi, G.;
    • Manconi, P. E.;
    • Vullo, V.;
    • Preziosi, R.;
    • Cirioni, O.;
    • Verucchi, G.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1.

    Published in:
    2018
    By:
    • Stella-Ascariz, Natalia;
    • Montejano, Rocio;
    • Rodriguez-Centeno, Javier;
    • Alejos, Belen;
    • Schwimmer, Christine;
    • Bernardino, Jose I;
    • Rodes, Berta;
    • Allavena, Clotilde;
    • Hoffmann, Christian;
    • Gisslén, Magnus;
    • de Miguel, Rosa;
    • Esteban-Cantos, Andrés;
    • Wallet, Cédrick;
    • Raffi, François;
    • Arribas, Jose R;
    • NEAT 001/ ANRS 143 Study Group
    Publication type:
    journal article
    29

    Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 3, p. 354, doi. 10.1093/infdis/jiu051
    By:
    • Castagna, Antonella;
    • Maggiolo, Franco;
    • Penco, Giovanni;
    • Wright, David;
    • Mills, Anthony;
    • Grossberg, Robert;
    • Molina, Jean-Michel;
    • Chas, Julie;
    • Durant, Jacques;
    • Moreno, Santiago;
    • Doroana, Manuela;
    • Ait-Khaled, Mounir;
    • Huang, Jenny;
    • Min, Sherene;
    • Song, Ivy;
    • Vavro, Cindy;
    • Nichols, Garrett;
    • Yeo, Jane M.
    Publication type:
    Article
    30
    31

    Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial.

    Published in:
    Journal of Infectious Diseases, 2013, v. 208, n. 9, p. 1436, doi. 10.1093/infdis/jit453
    By:
    • Hatano, Hiroyu;
    • Strain, Matthew C.;
    • Scherzer, Rebecca;
    • Bacchetti, Peter;
    • Wentworth, Deborah;
    • Hoh, Rebecca;
    • Martin, Jeffrey N.;
    • McCune, Joseph M.;
    • Neaton, James D.;
    • Tracy, Russell P.;
    • Hsue, Priscilla Y.;
    • Richman, Douglas D.;
    • Deeks, Steven G.
    Publication type:
    Article
    32
    33
    34
    35
    36

    Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing.

    Published in:
    Journal of Infectious Diseases, 2012, v. 205, n. 4, p. 557, doi. 10.1093/infdis/jir821
    By:
    • Armenia, Daniele;
    • Vandenbroucke, Ina;
    • Fabeni, Lavinia;
    • Van Marck, Herwig;
    • Cento, Valeria;
    • D'Arrigo, Roberta;
    • Van Wesenbeeck, Liesbeth;
    • Scopelliti, Fernanda;
    • Micheli, Valeria;
    • Bruzzone, Bianca;
    • Lo Caputo, Sergio;
    • Aerssens, Jeroen;
    • Rizzardini, Giuliano;
    • Tozzi, Valerio;
    • Narciso, Pasquale;
    • Antinori, Andrea;
    • Stuyver, Lieven;
    • Perno, Carlo Federico;
    • Ceccherini-Silberstein, Francesca
    Publication type:
    Article
    37
    38
    39
    40
    41

    A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response.

    Published in:
    Journal of Infectious Diseases, 2011, v. 203, n. 7, p. 960, doi. 10.1093/infdis/jiq138
    By:
    • Hatano, Hiroyu;
    • Hayes, Timothy L.;
    • Dahl, Viktor;
    • Sinclair, Elizabeth;
    • Lee, Tzong-Hae;
    • Hoh, Rebecca;
    • Lampiris, Harry;
    • Hunt, Peter W.;
    • Palmer, Sarah;
    • McCune, Joseph M.;
    • Martin, Jeffrey N.;
    • Busch, Michael P.;
    • Shacklett, Barbara L.;
    • Deeks, Steven G.
    Publication type:
    Article
    42
    43

    New-Onset Saquinavir-Induced Diabetes.

    Published in:
    Diabetes Care, 2013, v. 36, n. 12, p. e199, doi. 10.2337/dc13-1645
    By:
    • VAN ZOELEN, MARIEKE A. D.;
    • HOEPELMAN, A. I. M.;
    • DE VALK, H. W.
    Publication type:
    Article
    44
    45
    46

    Long-term successful control of super-multidrug-resistant human immunodeficiency virus type 1 infection by a novel combination therapy of raltegravir, etravirine, and boosted-darunavir.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 1, p. 105, doi. 10.1007/s10156-010-0082-4
    By:
    • Nakamura, Hitomi;
    • Miyazaki, Naoko;
    • Hosoya, Noriaki;
    • Koga, Michiko;
    • Odawara, Takashi;
    • Kikuchi, Tadashi;
    • Koibuchi, Tomohiko;
    • Kawana-Tachikawa, Ai;
    • Fujii, Takeshi;
    • Miura, Toshiyuki;
    • Iwamoto, Aikichi
    Publication type:
    Article
    47
    48
    49
    50